COLUMN GROUP III LP 13D and 13G filings for Tenaya Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:19 pm Purchase | 2024-02-12 | 13D | Tenaya Therapeutics, Inc. TNYA | COLUMN GROUP III LP | 13,599,275 17.700% | 2,229,001 (+19.60%) | Filing |
| 2023-02-21 5:26 pm Purchase | 2023-02-08 | 13D | Tenaya Therapeutics, Inc. TNYA | COLUMN GROUP III LP | 11,370,274 17.800% | 1,754,890 (+18.25%) | Filing |
| 2022-12-01 4:13 pm Purchase | 2022-11-21 | 13D | Tenaya Therapeutics, Inc. TNYA | COLUMN GROUP III LP | 9,615,384 15.000% | 215,094 (+2.29%) | Filing |
| 2022-02-11 4:36 pm Purchase | 2021-12-31 | 13G | Tenaya Therapeutics, Inc. TNYA | COLUMN GROUP III LP | 9,400,290 22.800% | 9,400,290 (New Position) | Filing |